We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!! | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

« Evaluating the Genetic Profiles of Tumor Cells circulating in the Bloodstream could transform Cancer Care: A Blood Test for managing Lung Cancer @Stanford University Medical School

Dr. Jennifer Doudna (UC Berkeley): PMWC 2017 Luminary Award, January 22, 2017 @PMWC 2017, January 23-25, Silicon Valley »

We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!!

December 19, 2016 by 2012pharmaceutical

We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!!

Curator and Open Access Journal Editor-in-Chief: Aviva Lev-Ari, PhD, RN

April 30, 2012: Launch Date for 1st Article

December 19, 2016: Date we Celebrate 5,000 Scientific Articles and 1,118,520 e-Readers

For 2016, Our Top Articles by e-Readers Views and Authors are:

Top Posts for 365 days ending 2016-12-19 (Summarized)

2015-12-20 to Today

Article Title

e-Views

>500

Home page / Archives

119,586

Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)

Curators: Vivek Lal, MBBS, MD, FCIR, Justin D Pearlman, MD, PhD, FACC and Article Curator: Aviva Lev-Ari, PhD, RN

2,815

Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?

Author: Larry H. Bernstein, MD, FCAP

2,501

Paclitaxel vs Abraxane (albumin-bound paclitaxel)

Author: Tilda Barliya, PhD

1,949

Recent comprehensive review on the role of ultrasound in breast cancer management

Writer, Reporter and Curator: Dror Nir, PhD

1,785

Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care

Curator: Aviva Lev-Ari, PhD, RN

1,523

AstraZeneca’s WEE1 protein inhibitor AZD1775 Shows Success Against Tumors with a SETD2 mutation

Curator: Stephen J. Williams, PhD

1,380

Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications

Curator: Aviva Lev-Ari, PhD, RN

1,256

Akt inhibition for cancer treatment, where do we stand today?

Author: Ziv Raviv, PhD

1,130

Targeting the Wnt Pathway [7.11]

Writer and Curator: Larry H Bernstein, MD, FCAP

923

Monoclonal Antibody Therapy and Market

Author and Curator: Demet Sag, PhD, CRA, GCP

888

Mesothelin: An early detection biomarker for cancer (By Jack Andraka)

Author/ Curator: Tilda Barliya PhD

819

Lipid Metabolism

Reporter and Curator: Larry H. Bernstein, MD, FCAP

808

Update on FDA Policy Regarding 3D Bioprinted Material

Curator: Stephen J. Williams, PhD

716

The Centrality of Ca(2+) Signaling and Cytoskeleton Involving Calmodulin Kinases and Ryanodine Receptors in Cardiac Failure, Arterial Smooth Muscle, Post-ischemic Arrhythmia, Similarities and Differences, and Pharmaceutical Targets

Author and Curator: Larry H Bernstein, MD, FCAP

Author, and Content Consultant to e-SERIES A: Cardiovascular Diseases: Justin Pearlman, MD, PhD, FACC

and

Curator: Aviva Lev-Ari, PhD, RN

676

Sexed Semen and Embryo Selection in Human Reproduction and Fertility Treatment

Reporter and Curator: Dr. Sudipta Saha, PhD

667

In focus: Circulating Tumor Cells

Author/Curator: Ritu Saxena, PhD

642

A Primer on DNA and DNA Replication

Reporter and Curator: Larry H. Bernstein, MD, FCAP

622

Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging

Reporter: Dror Nir, PhD

614

Our TEAM

599

Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad

Curator: Demet Sag, PhD, CRA, GCP

596

Pacemakers, Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT)

Curators: Justin D Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN

583

LPBI Group

575

U.S. FDA advisers recommend approval of Cinqair (Reslizumab,Teva) asthma drug for adults

Reporter: Aviva Lev-Ari, PhD, RN

568

FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules

Author-Writer: Stephen J. Williams, PhD

560

Biochemistry of the Coagulation Cascade and Platelet Aggregation – Part I

Curator, Editor and Writer: Larry H. Bernstein, MD, FCAP

559

Alternative Designs for the Human Artificial Heart: Patients in Heart Failure – Outcomes of Transplant (donor)/Implantation (artificial) and Monitoring Technologies for the Transplant/Implant Patient in the Community

Authors and Curators: Larry H Bernstein, MD, FCAP and Justin D Pearlman, MD, PhD, FACC

and

Article Curator and Reporter: Aviva Lev-Ari, PhD, RN

549

7th Annual – CHI’s Inflammation Inhibitors Small Molecule and Macrocyclic Approaches, April 19-20, 2016 Hilton San Diego Resort and Spa

Reporter: Aviva Lev-Ari, PhD, RN

536

Newer Treatments for Depression: Monoamine, Neurotrophic Factor & Pharmacokinetic Hypotheses

Curator: Zohi Sternberg, PhD

525

LIK 066, Novartis, for the treatment of type 2 diabetes

Curator: Larry H. Bernstein, MD, FCAP

524

Who will be the the First to IPO: Novartis bought in to Intellia (UC, Berkeley) as well as Caribou (UC, Berkeley) vs Editas (MIT)??

Reporter: Aviva Lev-Ari, PhD, RN

516

Interaction of enzymes and hormones

Reporter and Curator: Dr. Sudipta Saha, PhD

507

Writer and Curator: Larry H Bernstein, MD, FCAP

500

These articles and others are in EIGHT e-Books on Amazon.com

Forthcoming SEVEN e-Books in 2016

https://www.linkedin.com/pulse/forthcoming-cover-pages-new-e-books-medicine-from-lev-ari-phd-rn?trk=prof-post

WE ARE ON AMAZON.COM

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

BioMedical e-Books e-Series:

Cardiovascular, Genomics, Cancer, BioMed, Patient Centered Medicine

https://pharmaceuticalintelligence.com/biomed-e-books/

2013 e-Book on Amazon.com

Perspectives on Nitric Oxide in Disease Mechanisms, on Amazon since 6/2/12013

http://www.amazon.com/dp/B00DINFFYC

2015 e-Book on Amazon.com

Metabolic Genomics and Pharmaceutics, on Amazon since 7/21/2015

http://www.amazon.com/dp/B012BB0ZF0

Cancer Biology & Genomics for Disease Diagnosis, on Amazon since 8/11/2015

http://www.amazon.com/dp/B013RVYR2K

Genomics Orientations for Personalized Medicine, on Amazon since 11/23/2015

http://www.amazon.com/dp/B018DHBUO6

Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, on Amazon.com since 12/27/2015

http://www.amazon.com/dp/B019VH97LU

Cardiovascular, Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation, on Amazon since 11/30/2015

http://www.amazon.com/dp/B018Q5MCN8

Cardiovascular Diseases, Volume Three: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics, on Amazon since 11/29/2015

http://www.amazon.com/dp/B018PNHJ84

Cardiovascular Diseases, Volume Four: Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases, on Amazon since 12/26/2015

http://www.amazon.com/dp/B019UM909A

Advertisements

Posted in CRISPR/Cas9 & Gene Editing, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management | Leave a Comment

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

You are commenting using your Google+ account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: